Carter Jennifer L. 4
4 · Oncocyte Corp · Filed Jul 19, 2022
Insider Transaction Report
Form 4
Carter Jennifer L.
Director
Transactions
- Exercise/Conversion
Common Stock, no par value
2022-06-24+10,000→ 10,000 total - Exercise/Conversion
Restricted Stock Units
2022-06-24−10,000→ 0 totalExercise: $0.00→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The Restricted Stock Units vested on June 24, 2022.